Albumin Use in Patients With Cirrhosis in France: Results of the 'ALBU-LIVE' Survey

Autor: Garioud, Armand, Cadranel, Jean-François, Pauwels, Arnaud, Nousbaum, Jean-Baptiste, Thévenot, Thierry, Dao, Thong, Louvet, Alexandre, Sogni, Philippe, Talbodec, Nathalie, Antonini, Teresa, Bureau, Christophe, Thabut, Dominique, Elkrief, Laure, Jouannaud, Vincent, Macaigne, Gilles, Bernard-Chabert, Brigitte, Lison, Hortensia, Alric, Laurent, Carbonell, Nicolas, Labadie, Héléne, Amiot, Xavier, Abergel, Armand, Hanslik, Bertrand, Leroy, Vincent, De Lédinghen, Victor, Denis, Jacques

Publikováno v: Journal of Clinical Gastroenterology
Journal of Clinical Gastroenterology, Lippincott, Williams & Wilkins, 2017, 51 (9), pp.831-838. ⟨10.1097/MCG.0000000000000735⟩
Journal of Clinical Gastroenterology, 2017, 51 (9), pp.831-838. ⟨10.1097/MCG.0000000000000735⟩

International audience; IntroductionThe use of human albumin for the management of cirrhosis has increased. Recommendations have been published for therapeutic paracentesis (TP), spontaneous bacterial peritonitis (SBP), and type 1 hepatorenal syndrom

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c8cd4d2b3d1719e7b7566f7e52aebdcd
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03149673